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Since their introduction in 1985, oxygen concentrators have only been recommended when domiciliary oxygen is 
used for over 8 h day - i. Subsequent changes in the prices of oxygen merit a reappraisal of the prescribing of 
concentrators and cylinders when oxygen is used for less than 8 h day- ‘. 
Twenty-six patients in two health districts who used oxygen for less than 8 h day- i completed a crossover study 
in which each group received oxygen from each source for consecutive 3-month periods. The patients were visited 
at home before and during the study, and on each visit they completed a questionnaire asking about their use of 
oxygen, how acceptable they found the two sources and about several dimensions of their quality of life. The 
theoretical minimum cost of cylinder supply, the actual cost of cylinder supply and the average concentrator costs 
were assessed. 
The patients found the concentrators to be more acceptable, more useful and less obtrusive than cylinders. They 
used more oxygen in more rooms of the home during treatment with concentrators, and there were improvements 
in the quality-of-life measurements. The costing information showed that, both in theory and in practice, oxygen 
concentrators are cheaper than cylinders when oxygen is used for more than about 1.4 h day- ‘. 
These results suggest that the provisions for the supply of domiciliary oxygen should be reviewed and that 
concentrators should be recommended for patients who use more than around 1.4 h day - ‘. 
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Introduction 
The oxygen concentrator service was introduced into the 
U.K. in December 1985, and has been primarily used for 
the delivery of long-term oxygen therapy (LTOT) for a 
minimum of 1.5 h day - ’ for suitable patients. There is also 
provision for concentrators for patients who use oxygen, 
for indications other than LTOT, for more than 8 h day - ’ 
(the equivalent of 21 cylinders per month at 2 1 min- ‘) (1) 
for which the concentrator was shown to be cheaper than 
cylinders. Since the introduction of the service, there have 
been major changes in the prices of oxygen treatment, 
which merit a reappraisal of the costs and benefits of 
oxygen concentrators and cylinders. 
This study does not address the merits of short burst 
treatment but, accepting that oxygen is frequently pre- 
scribed for this indication, it evaluates the relative cost 
effectiveness of the two methods available for its delivery. 
Both the theoretical and the actual cost of cylinder 
supply of oxygen has been compared to the cost of concen- 
trators to patients who use between 1 and 8 h day - ’ of 
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oxygen in two health districts. Also, the patients’ view of 
the acceptability of the two systems and any accompanying 
effects on their quality of life were also examined, in order 
to assess whether cylinders or concentrators are preferable. 
Methods 
The Cambridge and Suffolk local medical committees and 
the Cambridgeshire and Suffolk family health service 
authorities gave permission for this study to be performed. 
The study had ethical committee approval from the 
Cambridge, West Suffolk, East Suffolk, Peterborough and 
Huntingdon health authorities. It was performed between 
March and August 1993. 
A comprehensive list of all patients who were authorised 
oxygen cylinder users and registered as having a cylinder 
head was obtained from the Cambridgeshire and Suffolk 
Family Health Services Authorities (FHSAs). The patients’ 
GPs were contacted to seek permission to approach them. 
The first contact was made by telephone at which it was 
established whether they used oxygen on average for more 
than 1 h day - ‘. Those that did were invited to take part in 
the study. Patients were excluded if they were current 
smokers or if they required oxygen cylinders in order to use 
a small portable oxygen cylinder. The crossover design of 
the study entailed patients using each system for 3 months. 
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TABLE 1. Physiological measurements prior to the study 
Cambridgeshire 
Suffolk 
Overall 
FEV, (1) (SD) FVC (1) (SD) 
0.75 (0.3) 1.23 (0.57) 
0.68 (0.31) 1.12 (0.28) 
0.72 (0.3) 1.18 (0.47) 
PEF (1 min - ‘) (SD) 
137 (69.5) 
99 (49) 
121 (63.5) 
sao, (%) (SD) 
93 (4) 
93 (2) 
93 (3.25) 
The Cambridgeshire patients received a concentrator sup- 
ply of oxygen for the first half of the study and cylinder 
supply for the second, and vice versa for the Suffolk 
patients. Each patient was visited on six occasions. The first 
followed the initial screening telephone contact and they 
were then visited at the start of the study and after 4 and 12 
weeks in each treatment limb. On each visit, the patients 
completed a questionnaire about their use of oxygen. This 
included a series of visual analogue scale (VAS) questions 
asking about several aspects of the oxygen systems, includ- 
ing the acceptability of the oxygen system, how obtrusive it 
was and how useful they found it (see Appendix 1). An 
assessment of quality of life was also performed using 
the questions concerning fatigue, emotional function and 
mastery from the chronic respiratory disease questionnaire 
(2) adapted to VAS measurement. At each visit, the 
patients’ forced expiratory volume in 1 s (FEV,), forced 
vital capacity (FVC) and peak expiratory flow rate (PEF) 
were measured using a turbine spirometer (Micromedical 
Ltd), as well as the resting oxygen saturation breathing air 
(SaO,) using a pulse oximeter (Minolta Pulsox-7 oximeter). 
The repeatability of the VAS scores was assessed between 
the first and immediate pre-study home visits using the 
method described by Bland and Altman (3). The mean VAS 
scores for each group of questions and the physiological 
measurements in each limb of the study for each patient 
were compared with the patients’ mean values in the other 
limb using the Wilcoxon matched pairs signed rank test. 
The theoretical minimum cost of cylinder supply was 
calculated from the drug tariff assuming that the maximum 
of three cylinders were delivered to the patients’ home at 
one time, the delivery distance was the minimum (O-3 
miles), the patients used the medium setting (2 1 min - ‘) and 
that all the oxygen in the cylinders was fully used up. The 
actual costs of the cylinder supply for 3 months, both prior 
to the study and within the study, were provided by the 
prescription pricing authority. The oxygen concentrators 
were installed by the regional contractors (DeVilbiss Health 
Care U.K. Ltd) who also supplied costing data based on the 
average of their contract prices in the U.K. assuming a 
patient survival of 18 months and a back-up oxygen 
cylinder provision for 80% of patients. 
Patients 
Seven hundred and thirty-two patients were registered with 
the FHSAs as having an oxygen set. Of’these, 227 (31%) 
were found to be deceased and a further 95 (13%) were no 
longer registered with the GP indicated on the FHSA 
database and could not be traced. The GPs declined 
permission to approach 111 patients (15.2%), and 50 
patients (6.8%) were already using oxygen concentrators 
rather than cylinders. Two hundred and forty-nine patients 
were contacted by telephone, of which 63 patients thought 
that they used more than 1 h day-’ of oxygen. Eight 
patients were excluded because of a chest infection in the 
4 weeks immediately preceding the study, and 26 patients 
declined to take part. Twenty-nine patients started the 
study but three patients in Cambridgeshire withdrew from 
the study while it was in progress because they were 
unwilling to change back from concentrator to cylinder 
treatment. 
Fifteen patients in Cambridgeshire (12 male and three 
female, mean age 74 years) and 11 in Suffolk (seven male 
and four female, mean age 73 years) completed the study. 
The clinical diagnosis in all patients was chronic obstructive 
pulmonary disease (COPD). There were no significant 
differences between the two groups of patients in their 
physiological measurements at the start of the study 
(Table 1). Prior to the study, the Cambridgeshire patients 
had used oxygen cylinders for a mean of 65.6 months (range 
14-111 months) and the Suffolk patients for a mean of 92.6 
months (21-252 months) (overall mean 76.4 months). 
Results 
OXYGEN TREATMENT COST 
The theoretical cost of oxygen cylinder supply, the actual 
cost of cylinder treatment for the study patients, both in the 
study and for the previous 3 months, and the concentrator 
cost are shown in Fig. 1. This shows that concentrator 
supply of oxygen is cheaper than cylinder supply for 
patients who use an average of greater than about 1.4 h 
day- ‘. This price relationship was true for both the 
theoretical minimum cylinder cost and for the actual 
cylinder costs both prior to and within the study. 
USE OF OXYGEN 
All of the patients reported that they used oxygen for 
breathlessness associated with activities of daily living. The 
patients used more oxygen in both limbs of the study than 
in the 3 months prior to the study (Fig. 2). Within the study, 
the patients used more oxygen while using a concentrator. 
The Cambridgeshire patients used a mean of 2.5, cylinder h 
day-’ and 5 concentrator h day - ‘, and the Suffolk 
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FIG. 1. The concentrator cost (w) and the theoretical and 
actual costs of cylinder supply of oxygen. 0, theoretical 
minimum cylinder cost; +, cylinder costs 3 months prior 
to study; x , cylinder costs within study. 
patients used 4.5 cylinder h day ~ i and 8.25 concentrator h 
day-‘. 
PHYSIOLOGICAL MEASUREMENTS 
There were no significant differences in the FEV,, FVC, 
PEF or resting oxygen saturation in either group of patients 
during the two limbs of the study (Table 2). ^ - 
0’ 
Pre-study Concentrator Cylinder 
Visual Analogue Scale Questions 
REPEATABILITY OF QUESTION SCORES 
The maximum possible score for each group of questions 
was 30, apart from the obtrusiveness group which had a 
maximum of 20. The scores in the initial and immediate 
pretreatment visits showed good repeatability with coef- 
ficients of repeatability of Fatigue (4) emotional function 
(6.7), mastery (7.6) ease of use (10.6), patient satisfaction 
(8.4) and obtrusiveness (5.8). 
QUALITY OF LIFE AND PATIENT 
ACCEPTABILITY OF OXYGEN CYLINDERS AND 
CONCENTRATOR 
Both groups of patients indicated improvements in all 
groups of questions when receiving oxygen from a concen- 
trator compared with cylinder supply (Fig. 3). These 
changes were all statistically significant (WO.05) except 
the change in ‘mastery’ in the Suffolk patients (P=O.12). 
Overall, the patients found the nasal cannulae (which 
were provided with the oxygen concentrator) and the face 
mask (that comes with the standard oxygen set) equally 
comfortable. 
Discussion 
The value of short burst oxygen treatment for symptomatic 
use by dyspnoeic patients with chronic lung disease has not 
24, 
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FIG. 2. The number of hours per day of oxygen used prior to and during the study. (a) Cambridgeshire, (b) Suffolk. -, 
Mean (standard error) of patient group; . ., individual patients. 
P = 0.027 
P = 0.015 
P = 0.0125 
P = 0.01 
P = 0.0015 
P = 0.008 
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TABLE 2. Physiological measurements in the two treatment limbs 
First limb of study Second limb of study 
[mean (so)] [mean (so)] 
Cambridgeshire 
Suffolk 
FEV, (1) 
FVC (1) 
PEF (1 min- ‘) 
SaO, (%) 
FEV, (1) 
FVC (1) 
PEF (1 min - ‘) 
SaO, (Y/0) 
0.84 (0.39) 0.84 (0.39) 
1.24 (0.49) 1.18 (0.52) 
153 (83) 152 (75) 
93 (1.6) 92 (2.5) 
0.65 (0.26) 0.62 (0.3) 
1.05 (0.32) 1.05 (0.32) 
120 (66) 115 (79) 
92 (1.7) 91 (2) 
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FIG. 3. The mean visual analogue scale (VAS) scores for the quality of life and patient acceptability questions (higher 
values represent better result). (a) Cambridgeshire, (b) Suffolk. 
been studied in controlled trials. The benefits are difficult to 
judge, particularly since there is a large placebo response to 
oxygen used in this way. Nonetheless, it is frequently 
prescribed and accounts for the majority of expenditure on 
oxygen in the U.K. -costing a total of g14.2 million in 
1991-92 compared with E6.9 million for the oxygen con- 
centrator service (4). This study does not address the 
arguments regarding the merits of short burst treatment 
but, accepting that oxygen is frequently prescribed for this 
indication, it evaluates the relative cost effectiveness of 
the two methods available for its delivery. 
The study has highlighted some important aspects of the 
cost of oxygen treatment. Thirty-eight percent of the 
patients who were registered with the FHSAs as authorised 
users of cylinder oxygen were either deceased or had 
changed to an oxygen concentrator, and a further 13% 
could not be traced because of inaccurate information 
regarding the registered GP. This has important cost impli- 
cations since the monthly reimbursement to pharmacists for 
each oxygen set supplied is based on the FHSA list. The sets 
assigned to patients who are no longer using cylinders must 
be either unused or re-issued to other patients - duplicating 
the reimbursement. Although the charge for each oxygen 
set is only small (L2.03 month- ‘), it may represent 
a significant cumulative cost if these findings are 
representative of the U.K. as a whole. 
The gradual changes in both cylinder and concentrator 
costs since 1985 have changed the point, in number of hours 
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per day of oxygen, at which concentrator supply becomes 
cheaper (the cost crossover point). The authors’ theoretical 
calculations of the minimum cost of cylinder oxygen, based 
on drug tariff charges, are very close to the actual costs for 
the patients. The present actual and theoretical cost cross- 
over point is around 1.4 h day- ’ rather than the presently 
recommended 8 h day - ‘. These calculations have assumed 
an average patient survival of 18 months which seems 
reasonable since the patients in this study had used cylin- 
ders for a mean period of 76 months prior to the study. 
Assuming an average patient survival of 6 or 36 months, the 
cost crossover point would be 1.7 or 1.35 h day - i, respect- 
ively. This and other work (5) suggest that the majority of 
patients who have cylinders use oxygen only infrequently 
and intermittently with the 1.4 h day - i threshold exceeded 
by around 10% of them. 
The authors have shown that access to concentrator 
supply may be associated with an increase in the number of 
hours per day of oxygen used by the patients. The overall 
cost of the concentrator service is only marginally changed 
by this increased usage since the majority of the cost is a 
fixed monthly charge for the machine installation, service 
and rental with a relatively small component of electricity 
cost. Even if the concentrator usage is increased to 24 h 
day- ‘, the resulting cost would only be equivalent to 
around 1.8 h day - i of cylinder oxygen. Similarly, potential 
changes to taxation on domestic fuel would have little effect 
on the cost crossover point. If patients use oxygen at the 
high (4 1 min - ‘) cylinder setting, the cost crossover point is 
reduced to around 0.7 h day - ’ since the cylinder cost is 
doubled whereas the concentrator cost is the same at any 
flow rate. The patients found the oxygen concentrator a 
more useful and acceptable means of oxygen delivery, and 
the VAS results also suggested that this may be associated 
with improvements in several dimensions of quality of life. 
These results must be interpreted with some caution since 
the patients were not blind to the treatment they were 
receiving, and may have been influenced by several factors 
such as the novelty of the concentrator and the increased 
interest shown in them associated with the study. Clearly, 
however, the use of oxygen concentrators was not associ- 
ated with any reduction of patient acceptability. The 
improvements may well be real since all of the patients used 
oxygen for symptomatic relief of shortness of breath, and 
concentrators can be more widely used around the home 
than cylinders. These are usually only available in one or 
two areas of the home, and because of the short length of 
oxygen tubing that is supplied, patients are usually 
restricted to using oxygen after activity. The concentrator 
service includes the installation of oxygen delivery tubing to 
wherever the patient may require oxygen, and ‘trailing 
leads’ allow its use during activity which may improve 
confidence and mobility. 
The patients in this study took advantage of this facility, 
using oxygen in more rooms and for more hours per day 
during concentrator treatment. They also reported that 
the concentrator was less ‘in the way’ and occupied 
less space in the home, presumably because cylinders must 
be positioned in the main areas of use-usually the 
bedroom and living room -whereas the concentrators can 
be installed in a less prominent position away from the 
main living areas. Other factors that may have contributed 
to the improvements in the VAS question scores include 
the lack of need for repeat prescriptions, less fear of 
running out of oxygen, and not having to wait for a 
cylinder delivery. 
This study of patients who use oxygen for less than 8 h 
day- i suggests that a concentrator supply would be better 
accepted by these patients and would be more cost effective 
than cylinder supply for those patients who regularly use 
more than about 1.4 h day- i (or 4 cylinders month ~ ’ at 
2 1 min - ‘). These results suggest that the present recom- 
mendations for oxygen concentrator prescription should be 
modified. 
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Appendix 1: Visual analogue scale 
questions 
PATIENT SATISFACTION GROUP 
1. Overall, how happy have you been with the present 
oxygen system? 
(Extremely happy . . Extremely unhappy) 
2. How relaxed have you felt whilst using the present 
oxygen system? I* 
(Extremely relaxed . . Not at all relaxed) 
3. Overall, how comfortable have you been while using the 
oxygen system? 
(Extremely comfortable Not at all comfortable) 
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USEFULNESS GROUP OBTRUSIVENESS GROUP 
1. Overall, how useful has your oxygen been to you? 
(Extremely useful Not at all useful) 
2. How convenient is your present oxygen system to use? 
(Extremely convenient Not at all convenient) 
3. Over the last 2 weeks, how free have you felt to move 
around the house while using oxygen? 
(Extremely free not at all free) 
1. How much ‘in the way’ is the present system? 
(At lot . Not at all) 
2. How much space has the oxygen system taken up? 
(No space at all A lot of space) 
